These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23585129)

  • 1. The sGC activator BAY 60-2770 has potent erectile activity in the rat.
    Lasker GF; Pankey EA; Frink TJ; Zeitzer JR; Walter KA; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1670-9. PubMed ID: 23585129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of erectile responses to BAY 41-8543 and muscarinic receptor stimulation in the rat.
    Lasker GF; Pankey EA; Allain AV; Dhaliwal JS; Stasch JP; Murthy SN; Kadowitz PJ
    J Sex Med; 2013 Mar; 10(3):704-18. PubMed ID: 22989320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme.
    Pankey EA; Bhartiya M; Badejo AM; Haider U; Stasch JP; Murthy SN; Nossaman BD; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H792-802. PubMed ID: 21217076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective Rho-kinase inhibitor azaindole-1 has long-lasting erectile activity in the rat.
    Lasker GF; Pankey EA; Allain AV; Murthy SN; Stasch JP; Kadowitz PJ
    Urology; 2013 Feb; 81(2):465.e7-14. PubMed ID: 23374844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
    Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
    BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of erectile responses to bradykinin in the anesthetized rat.
    Edward JA; Pankey EA; Jupiter RC; Lasker GF; Yoo D; Reddy VG; Peak TC; Chong I; Jones MR; Feintech SV; Lindsey SH; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2015 Aug; 309(3):H499-511. PubMed ID: 26055796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of erectile responses to imatinib in the rat.
    Pankey EA; Lasker GF; Gur S; Hellstrom WJ; Kadowitz PJ
    Urology; 2013 Jul; 82(1):253.e17-24. PubMed ID: 23806406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide.
    Badejo AM; Nossaman VE; Pankey EA; Bhartiya M; Kannadka CB; Murthy SN; Nossaman BD; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1153-9. PubMed ID: 20639220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
    McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
    J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
    PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
    Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.
    Echeverry MB; Salgado ML; Ferreira FR; da-Silva CA; Del Bel EA
    Psychopharmacology (Berl); 2007 Oct; 194(2):271-8. PubMed ID: 17593355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
    Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
    J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.
    Oudot A; Behr-Roussel D; Poirier S; Sandner P; Bernabé J; Alexandre L; Giuliano F
    Eur Urol; 2011 Nov; 60(5):1020-6. PubMed ID: 21839578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway.
    Reilly CM; Lewis RW; Stopper VS; Mills TM
    J Androl; 1997; 18(6):588-94. PubMed ID: 9432131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.